Aviva
USNA icon

Aviva’s Usana Health Sciences USNA Stock Holding History

Aviva’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,933
Closed -$538K – 904
2025
Q1 		$538K Buy
19,933
+4,156
+26% +$132K ﹤0.01% 787
2024
Q4 		$566K Sell
15,777
-1,040
-6% -$38.9K ﹤0.01% 766
2024
Q3 		$638K Buy
16,817
+3,668
+28% +$151K ﹤0.01% 767
2024
Q2 		$595K Buy
13,149
+134
+1% +$6.17K ﹤0.01% 794
2024
Q1 		$631K Buy
13,015
+331
+3% +$16.2K ﹤0.01% 817
2023
Q4 		$680K Buy
12,684
+2,819
+29% +$143K ﹤0.01% 750
2023
Q3 		$578K Sell
9,865
-12,842
-57% -$803K ﹤0.01% 825
2023
Q2 		$1.43M Sell
22,707
-581
-2% -$37K 0.01% 742
2023
Q1 		$1.46M Buy
23,288
+4,629
+25% +$276K 0.01% 758
2022
Q4 		$993K Sell
18,659
-6,670
-26% -$361K ﹤0.01% 834
2022
Q3 		$1.42M Sell
25,329
-2,791
-10% -$184K 0.01% 854
2022
Q2 		$2.04M Buy
28,120
+9,662
+52% +$720K 0.01% 799
2022
Q1 		$1.47M Sell
18,458
-6,704
-27% -$604K 0.01% 923
2021
Q4 		$2.55M Buy
25,162
+8,092
+47% +$807K 0.01% 786
2021
Q3 		$1.57M Buy
+17,070
New +$1.64M 0.01% 870
2021
Q2 		– Sell
-12,677
Closed -$1.24M – 977
2021
Q1 		$1.24M Buy
+12,677
New +$1.15M 0.01% 786

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Aviva's USNA Position: Q2 2025 in Review

Aviva sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 19,933 shares — an estimated $538K sold.

Aviva first reported a position in USNA in Q1 2021 and held it in 16 quarters. The position peaked at $2.55M in Q4 2021. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

  • Aviva reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
  • Aviva sold 19,933 Usana Health Sciences shares in Q2 2025, an estimated $538K.
  • Aviva first reported a position in Usana Health Sciences in Q1 2021 and held it in 16 quarters.
  • Aviva's Usana Health Sciences position peaked at $2.55M in Q4 2021.
  • 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Aviva's 13F filing for Q2 2025, filed 7 Aug 2025.